Filing Details
- Accession Number:
- 0001493152-21-009073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-19 06:15:24
- Reporting Period:
- 2021-04-16
- Accepted Time:
- 2021-04-19 06:15:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1460702 | Qualigen Therapeutics Inc. | QLGN | Pharmaceutical Preparations (2834) | 263474527 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1812553 | L. Christopher Lotz | C/O Qualigen Therapeutics, Inc., 2042 Corte Del Nogal Carlsbad CA 92011 | Vice President Of Finance, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-16 | 2,700 | $1.86 | 12,541 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
